Table of Contents
Table 5-9: Cass
Table 5-11: Clay
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 285 | 661.2 | 1,300 | 630.0 | 116 | 276.2 | 600 | 304.1 |
| Esophagus | * | # | 11 | 5.2** | * | # | 13 | 6.5** |
| Stomach | 5 | 11.3** | 25 | 11.7 | * | # | 13 | 6.0** |
| Colon excluding Rectum | 21 | 54.7 | 110 | 56.7 | 10 | 23.0** | 59 | 31.4 |
| Rectum and Rectosigmoid Junction | 5 | 11.2** | 44 | 21.7 | * | # | 10 | 4.6** |
| Liver | 5 | 10.1** | 6 | 2.5** | * | # | 6 | 3.1** |
| Pancreas | 5 | 11.3** | 20 | 9.2 | 5 | 11.7** | 18 | 8.9** |
| Lung and Bronchus | 53 | 128.4 | 266 | 132.3 | 53 | 125.7 | 244 | 122.5 |
| Melanoma of the Skin | 8 | 19.2** | 32 | 15.0 | * | # | 5 | 2.0** |
| Prostate | 92 | 213.0 | 377 | 185.6 | 11 | 28.3** | 47 | 26.7 |
| Urinary Bladder | 12 | 29.9** | 92 | 45.7 | * | # | 21 | 12.0 |
| Kidney and Renal Pelvis | 8 | 16.1** | 45 | 20.5 | * | # | 17 | 8.0** |
| Brain and Other Nervous System | 6 | 15.1** | 25 | 11.7 | * | # | 17 | 8.0** |
| Non-Hodgkin Lymphoma | 8 | 19.4** | 37 | 16.9 | * | # | 17 | 8.7** |
| Myeloma | * | # | 10 | 4.7** | * | # | 13 | 6.2** |
| Leukemia | 5 | 11.7** | 25 | 12.3 | * | # | 18 | 9.4** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 250 | 441.3 | 1,213 | 442.6 | 112 | 194.5 | 527 | 188.2 |
| Colon excluding Rectum | 19 | 32.4** | 111 | 39.4 | 7 | 11.7** | 56 | 19.6 |
| Rectum and Rectosigmoid Junction | 6 | 10.3** | 36 | 12.8 | * | # | 7 | 2.4** |
| Liver | * | # | 8 | 3.0** | * | # | 8 | 2.9** |
| Pancreas | 5 | 8.7** | 20 | 7.2 | 6 | 11.1** | 18 | 6.6** |
| Lung and Bronchus | 42 | 73.4 | 209 | 75.1 | 40 | 69.1 | 163 | 58.2 |
| Melanoma of the Skin | 6 | 10.1** | 34 | 12.7 | * | # | 5 | 1.7** |
| Breast | 85 | 149.4 | 381 | 140.0 | 13 | 22.6** | 85 | 30.5 |
| Cervix Uteri | 10 | 18.8** | 32 | 12.2 | * | # | 7 | 2.6** |
| Corpus Uteri | 9 | 15.5** | 54 | 19.6 | * | # | 5 | 1.8** |
| Ovary | 10 | 18.1** | 51 | 18.8 | 6 | 10.3** | 25 | 9.0 |
| Urinary Bladder | 5 | 8.7** | 26 | 9.4 | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 19 | 7.1** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 11 | 4.2** | * | # | 9 | 3.4** |
| Non-Hodgkin Lymphoma | 7 | 13.3** | 37 | 13.7 | * | # | 14 | 4.9** |
| Myeloma | 5 | 8.9** | 9 | 3.2** | * | # | 8 | 2.9** |
| Leukemia | * | # | 29 | 10.6 | 9 | 15.7** | 31 | 11.2 |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-9: Cass
Table 5-11: Clay
